Recently Posted Guidance Documents

Recently Posted Guidance Documents

8/27/2020 - CVM GFI #191 Changes to Approved NADAs - New NADAs vs. Category II Supplemental NADAs 8/27/2020 - Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products: Guidance for Industry 8/26/2020 - Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components: Guidance for Industry 8/25/2020 - Evaluating Cancer Drugs in Patients with Central Nervous System Metastases: Draft Guidance for Industry